Prometrium
Product Images NDC 54868-4250

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Prometrium (NDC 54868-4250). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of 100 mg Packaqe Label (100mg Package Label)

Image Of 100 mg Packaqe Label (100mg Package Label)
Prometrium 100 mg capsule label by Physicians Total Care, Inc. The label states it contains 30 capsules of progesterone, USP, with a caution not to use if allergic to peanuts. Additional information includes dosage instructions, storage conditions, and safety warnings. The label also features the NDC number 54868-4250-0 and a barcode.*
FDA Label Image

Image Of 200 mg Package Label (200mg Package Label)

Image Of 200 mg Package Label (200mg Package Label)
Prometrium 200 mg capsules bottle label by Physicians Total Care, Inc. Contains 30 capsules of progesterone USP. Includes warnings against use if allergic and cautions about prescription requirements. The label provides storage instructions and includes barcode and lot number information.*
FDA Label Image

Image Of Chemical Structure (Chemical Structure)

Image Of Chemical Structure (Chemical Structure)
Chemical structure of the active ingredient shown in the image, which is characteristic of Prometrium, a progesterone-based medication. The diagram depicts the molecular framework with carbon rings and functional groups typical to this compound.*
FDA Label Image

Image Of Figure 1 (Figure 1)

Image Of Figure 1 (Figure 1)
A line graph illustrating the probability of hyperplasia over time (months on medication) for three groups: Conjugated Estrogens Alone, Conjugated Estrogens Plus Micronized Progesterone (cyclical), and Placebo Only. The Y-axis represents the probability of hyperplasia, and the X-axis shows time intervals up to 36 months. Sample sizes for each interval are noted below the X-axis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.